Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 1, 2002, Pages 7-17

  Su, Z ^a   Braun, P J ^b   Klemp, K F ^a   Baker, K R ^a   Thames, E H ^a   Ortel, T L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BIOMÉRIEUX   (France)

Author keywords

Antiphospholipid antibodies; Diagnostic test; Lupus anticoagulant; Optical profiles; Transmittance waveforms

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; AGED; ANALYZER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASSAY; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; WAVEFORM;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; HUMANS; INDICATORS AND REAGENTS; KINETICS; WARFARIN;

EID: 0036235214     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200201000-00002     Document Type: Article

References (28)

1. Pathogenesis and treatment of the antiphospholipid antibody syndrome
2. Antiphospholipid syndrome in pregnancy. Obstetric concerns and treatment
3. Criteria for the diagnosis of lupus anticoagulants: An update
4. Diagnosis of antiphospholipid antibodies
5. Immunology of the antiphospholipid antibody syndrome
6. Laboratory identification of lupus anticoagulants: Results of the second international workshop for identification of lupus anticoagulants
7. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for blood coagulation
8. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants
9. Sensitivity of sixteen aPTT reagents for the presence of lupus anticoagulants
10. The varied sensitivity of partial thromboplastin and prothrombin time reagents in the demonstration of the lupus-like anticoagulant
11. Monitoring warfarin therapy in patients with lupus anticoagulants
12. Control of oral anticoagulation in patients with the antiphospholipid syndrome - Influence of the lupus anticoagulant on International Normalized Ratio
13. INR discrepancies with a recombinant thromboplastin in two patients with the antiphospholipid syndrome
14. Properties of optical data from activated partial thromboplastin time and prothrombin time assays
15. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation
16. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis
17. Predicting the presence of plasma heparin using neural networks to analyze coagulation screening assay optical profiles
18. Classification of factor deficiencies from coagulation assays using neural networks
19. Comparison of the kinetic fibrinogen assay with the von Clauss method and the clot recovery method in plasma of patients with conditions affecting fibrinogen coagulability
20. Method for the determination of functional (clottable) fibrinogen by the new family of ACL coagulometers
21. Risk factors associated with thrombosis in subjects with antiphospholipid antibodies
22. Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance
23. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results
24. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers
25. Clinical and laboratory manifestations of anti-factor V antibodies
26. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants
27. Thromboplastin sensitivity in waveform analysis
28. Optical waveform analysis is a very sensitive indicator of disseminated intravascular coagulation but not 100% specific